- Home
- RDZN vs BHST Comparison
RDZN vs BHST Comparison
Compare RDZN & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | RDZN | BHST |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Canada |
| Employees | 308 | 87 |
| Industry | Blank Checks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.7M | 97.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RDZN | BHST |
|---|---|---|
| Price | $1.33 | $4.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 104.4K | 25.6K |
| Earning Date | 02-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $33.77 | $146.27 |
| Revenue Next Year | $51.46 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $4.10 |
| 52 Week High | $2.56 | $12.80 |
Technical Indicators
Market Signals| Indicator | RDZN | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 57.37 | 49.30 |
| Support Level | $1.26 | $4.27 |
| Resistance Level | $1.46 | $5.02 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 57.89 | 26.34 |
Price Performance
Historical ComparisonAbout RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About BHST BioHarvest Sciences Inc.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.